Revenue: The sum of all revenue fields included for a company's operating activities.
Rigel Pharmaceuticals, Inc. (RIGL) had Revenue of $78.70M for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
|
Revenue |
$78.70M |
$17.29M |
|
$8.53M |
|
$70.18M |
|
$55.13M |
|
$23.57M |
|
$0.01M |
|
$23.59M |
|
$23.59M |
|
$17.29M |
|
$17.29M |
|
$17.29M |
|
$17.29M |
|
$23.57M |
|
$24.39M |
|
18.54M |
|
19.57M |
|
$0.93 |
|
$0.88 |
|
| Balance Sheet Financials | |
$185.53M |
|
-- |
|
$335.54M |
|
$521.07M |
|
$95.59M |
|
-- |
|
$0.06M |
|
$95.64M |
|
$425.42M |
|
$331.54M |
|
$425.42M |
|
18.65M |
|
| Cash Flow Statement Financials | |
$33.38M |
|
$9.48M |
|
$-22.62M |
|
$40.64M |
|
$60.87M |
|
$20.24M |
|
$10.30M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.94 |
|
-- |
|
-- |
|
-- |
|
0.09 |
|
89.17% |
|
29.95% |
|
29.95% |
|
-- |
|
29.97% |
|
21.97% |
|
$33.38M |
|
-- |
|
-- |
|
-- |
|
0.15 |
|
0.59 |
|
1.40 |
|
64.09 |
|
4.06% |
|
5.21% |
|
3.32% |
|
4.06% |
|
$22.81 |
|
$1.71 |
|
$1.71 |
|